B Faulques
YOU?
Author Swipe
View article: Sa2010 OPTICAL DIAGNOSIS OF SMALL COLORECTAL POLYPS USING OPTIVISTA AND ISCAN IMAGE ENHANCED ENDOSCOPY: A RANDOMIZED CONTROLLED TRIAL
Sa2010 OPTICAL DIAGNOSIS OF SMALL COLORECTAL POLYPS USING OPTIVISTA AND ISCAN IMAGE ENHANCED ENDOSCOPY: A RANDOMIZED CONTROLLED TRIAL Open
View article: Uptake and barriers for implementation of the resect and discard strategy: an international survey
Uptake and barriers for implementation of the resect and discard strategy: an international survey Open
Background and study aims Optical real-time diagnosis (= resect-and-discard strategy) is an alternative to histopathology for diminutive colorectal polyps. However, clinical adoption of this approach seems sparse. We were interested in eva…
View article: A239 CLINICAL MANAGEMENT OF COLORECTAL POLYPS: RESULTS OF AN INTERNATIONAL SURVEY
A239 CLINICAL MANAGEMENT OF COLORECTAL POLYPS: RESULTS OF AN INTERNATIONAL SURVEY Open
BACKGROUND: Endoscopic management of colorectal polyps continues to evolve. Alternatives to histopathology assessment for diminutive polyps such as the resect-and-discard strategy have been introduced while polypectomy guidelines have inco…
View article: Comparing outcomes for endoscopic submucosal dissection between Eastern and Western countries: A systematic review and meta-analysis
Comparing outcomes for endoscopic submucosal dissection between Eastern and Western countries: A systematic review and meta-analysis Open
Eastern countries show better ESD outcomes compared to Western countries. Availability of local ESD expertise and regional outcomes should be considered for decision making to treat gastrointestinal lesions with ESD.
View article: Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab
Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab Open
This is the first described case of grade 4 immune mucositis and esophagitis associated with pembrolizumab. Because the use of pembrolizumab is increasing in oncology, pharmacists and physicians should be aware of this rare manifestation.
View article: A256 COMPARING GLOBAL OUTCOMES FOR ENDOSCOPIC SUBMUCOSAL DISSECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
A256 COMPARING GLOBAL OUTCOMES FOR ENDOSCOPIC SUBMUCOSAL DISSECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS Open
BACKGROUND: Endoscopic submucosal dissection (ESD) has become the preferred approach to remove advanced gastrointestinal lesions in Asian countries while widespread adoption in the Western world remains limited. Studies evaluating differen…